Pamela Jones
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Dendreon Pharmaceuticals LLC at 38.2% of the total. 2025 is the largest year on record at $6,044, 3.1 times the $1,934 reported in 2021. Among family clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 315 payments — averaging $55.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dendreon Pharmaceuticals LLC$7K
- Pfizer$3K
- Johnson & Johnson$2K
- Bayer$2K
- Sumitomo Pharma America, Inc.$1K
- AstraZeneca$652
- plus $2K from 23 others
What the payments were for
- Consulting fees$4,23224%
- Speaking & faculty fees$2,98217%
- Travel & lodging$2,87717%
- Food & beverage$7,07141%
- Education$2642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 91 | $6,655 |
| Pfizer | 39 | $3,277 |
| Johnson & Johnson | 19 | $1,974 |
| Bayer | 15 | $1,605 |
| Sumitomo Pharma America, Inc. | 71 | $1,319 |
| AstraZeneca | 15 | $652 |
| Astellas Pharma US Inc | 12 | $301 |
| Urogen Pharma, Inc. | 12 | $280 |
| Merck | 5 | $207 |
| Myriad Genetic Laboratories, Inc. | 4 | $187 |
| Bioprotect Medical, Inc. | 1 | $165 |
| Progenics Pharmaceuticals, Inc. | 6 | $131 |
| Blue Earth Diagnostics | 1 | $129 |
| Procept Biorobotics Corporation | 1 | $115 |
| Medtronic | 1 | $69 |
| Tolmar, Inc. | 4 | $59 |
| Myovant Sciences Inc. | 2 | $54 |
| 180 Medical, Inc. | 2 | $34 |
| Immunitybio, Inc. | 2 | $32 |
| Novartis | 2 | $32 |
| Urovant Sciences Inc | 2 | $30 |
| Teleflex LLC | 1 | $19 |
| Tolmar Pharmaceuticals, Inc. | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Endo USA, Inc. | 1 | $16 |
| Verity Pharmaceuticals Inc. | 1 | $15 |
| AbbVie | 1 | $13 |
| Janssen Scientific Affairs, LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROVENGE$5,161
- Erleada$1,463
- LYNPARZA$404
- ORGOVYX$227
- BIOPROTECT BALLOON IMPLANT SYSTEM$165
- myRisk$155
- POSLUMA$129
- AKEEGA$125
- AQUABEAM SYSTEM$115
How this compares
$17,426 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Troy
- Daniela MaximTroy$112K
- Mackenzie DifioreTroy$11K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.